EUA
QIAreach SARS-CoV-2 Antigen
FDA Emergency Use Authorization · QIAGEN GmbH · May 18, 2023
Key facts
| Product | QIAreach SARS-CoV-2 Antigen |
|---|---|
| Company | QIAGEN GmbH |
| Product type | Digital Lateral Flow, Fluorescence, Instrument Read, Single Target |
| Date | May 18, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: